Though all eyes are on Congress as Election Day looms, U.S. health care may look more like a local issue when the polls close on Tuesday, experts say. That’s because new leaders in states that skipped Obamacare’s Medicaid expansion could extend health insurance to millions of Americans. John McDonough, a professor of the practice of… Read More: Harvard forum examines U.S. health care ahead of midterms »
Mona Randolph relies on one of the 700-lb. devices to keep her alive. With just three remaining in the United States, iron lungs are nearly obsolete — but Mona Randolph, a polio survivor, relies on one of the 700-lb. devices to keep her alive. The 82-year-old Randolph has used the device on and off since… Read More: Polio Survivor, 82, Is One of the Last 3 People… »
LONDON (Reuters) – GlaxoSmithKline said on Friday that U.S. health authorities had asked for more information about its Nucala drug for use in combating chronic obstructive pulmonary disease (COPD). FILE PHOTO: The GlaxoSmithKline (GSK) logo. March 21, 2018. REUTERS/Loriene Perera/File Photo GSK said it had received a complete response letter (CRL) from the U.S. Food… Read More: GSK says U.S. FDA wants more information on pulmonary drug »
Another such review examined how the number of prenatal visits affected infant mortality. Seven studies involved more than 60,000 women in countries of varying income. There was no difference in high-income countries in the number of deaths of those who had more or fewer visits (although the number of deaths over all was low). In… Read More: The New Health Care: The U.S. Is Failing in Infant… »